H. Skopelitis

CEA and CA-19.9 Serum Tumor Markers as Prognostic Factors in Patients with Locally Advanced (Unresectable) or Metastatic Pancreatic Adenocarcinoma: A Retrospective Analysis

A. Papalambros, N. Tsavaris, C. Kosmas, 2009, Journal of chemotherapy.

Prognostic significance of smoking in addition to established risk factors in patients with Dukes B and C colorectal cancer: a retrospective analysis.

H. Skopelitis, I. Xynos, M. Karadima, 2013, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Efficacy of tropisetron in patients with advanced non-small-cell lung cancer receiving adjuvant chemotherapy with carboplatin and taxanes.

N. Tsavaris, C. Kosmas, H. Skopelitis, 2008, European journal of cancer care.

Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study

J. Syrios, N. Tsavaris, C. Kosmas, 2007, Journal of Cancer Research and Clinical Oncology.

Second-line treatment with oxaliplatin, leucovorin and 5-fluorouracil in gemcitabine-pretreated advanced pancreatic cancer: A phase II study

E. Felekouras, E. Papalambros, N. Tsavaris, 2005, Investigational New Drugs.

Sequential Administration of 5-Fluorouracil (5FU)/Leucovorin (LV) Followed by Irinotecan (CPT-11) at Relapse versus CPT-11 Followed by 5-FU/LV in Advanced Colorectal Carcinoma

E. Felekouras, E. Papalambros, N. Tsavaris, 2007, Chemotherapy.

Methotrexate-Paclitaxel-Epirubicin-Carboplatin (M-TEC) Combination Chemotherapy in Patients with Advanced Bladder Cancer: An Open Label Phase II Study

C. Alamanis, N. Tsavaris, C. Kosmas, 2005, Journal of chemotherapy.

Docetaxel-Ifosfamide Combination in Patients with Advanced Breast Cancer Failing Prior Anthracycline- Based Regimens: Results of a Phase I-II Study

N. Malamos, N. Tsavaris, C. Kosmas, 2007, Journal of chemotherapy.

Dose escalation of docetaxel

N. Malamos, N. Tsavaris, C. Kosmas, 2005 .